Pharmacokinetic Investigation of UDCA in Bile and Serum

Dr. Falk Pharma

Status and phase: Completed; Phase 1

Conditions: Healthy

Treatments: Drug: UDCA

Study type: Interventional

Funder types: Industry

Identifiers

NCT00529009

URT-14/BIO

Details and patient eligibility

About

To assess the bile acid composition of cystic bile and serum pharmaco¬kinetics after a 3-week treatment with UDCA and to correlate pharmacokinetic parameters of UDCA in bile and serum during steady state.

Full description

see protocol

Sex: All

Ages: 18 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• PBC or healthy

Exclusion criteria

• pathology which does interfere with safety or PK of UDCA